BG-T187

Advertisement

cGxPJobs Banner

Silence Therapeutics Reports Positive Divesiran Phase 2 Data

London, August 10, 2026 Silence Therapeutics plc announced positive topline results from the Phase 2 SANRECO trial of divesiran...

By cGxPwire Editor
August 11, 2026

Read More

BeOne Medicines Partners with Revolution Medicines on RAS Cancer Therapies

San Carlos, Calif. & Redwood City, Calif., August 10, 2026 BeOne Medicines Ltd. and Revolution Medicines, Inc. announced a...

By cGxPwire Editor
August 10, 2026

Read More

Advertisement

cGxPJobs

Directory